Pravat Mandal, Ph.D. - Related publications

Affiliations: 
Johns Hopkins University, Baltimore, MD 
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2020 Yu SY, Zhu WL, Guo P, Li SW, Liu YO, Lian TH, Ding DY, Li DN, Li LX, Liu L, Zhao H, Zuo LJ, Hu Y, Yu QJ, Jin Z, et al. Clinical features and brain structural changes in magnetic resonance imaging in Alzheimer's disease patients with apathy. Aging. 12. PMID 33041262 DOI: 10.18632/aging.103705   
2020 Lee S, Kim KW, . Associations between texture of T1-weighted MRI and radiographic pathologies in Alzheimer's disease. European Journal of Neurology. PMID 33098172 DOI: 10.1111/ene.14609   
2020 Mo D, Li X, Raabe CA, Rozhdestvensky TS, Skryabin BV, Brosius J. Circular RNA Encoded Amyloid Beta peptides-A Novel Putative Player in Alzheimer's Disease. Cells. 9. PMID 33003364 DOI: 10.3390/cells9102196   
2020 van der Weerd L, Lefering A, Webb A, Egli R, Bossoni L. Effects of Alzheimer's disease and formalin fixation on the different mineralised-iron forms in the human brain. Scientific Reports. 10: 16440. PMID 33020534 DOI: 10.1038/s41598-020-73324-5   
2020 Moynier F, Borgne ML, Laoud E, Mahan B, Mouton-Ligier F, Hugon J, Paquet C. Copper and zinc isotopic excursions in the human brain affected by Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12112. PMID 33102682 DOI: 10.1002/dad2.12112   
2020 Tran AT, Pham TB, Kim JY, Tavares JMRS. Alzheimer's diagnosis using deep learning in segmenting and classifying 3D brain MR images. The International Journal of Neuroscience. 1-13. PMID 33045895 DOI: 10.1080/00207454.2020.1835900   
2020 Rivera-Marrero S, Bencomo-Martínez A, Orta Salazar E, Sablón-Carrazana M, García-Pupo L, Zoppolo F, Arredondo F, Dapueto R, Daniela Santi M, Kreimerman I, Pardo T, Reyes L, Galán L, León-Chaviano S, Espinosa-Rodríguez LA, et al. A new naphthalene derivative with anti-amyloidogenic activity as potential therapeutic agent for Alzheimer's disease. Bioorganic & Medicinal Chemistry. 28: 115700. PMID 33069076 DOI: 10.1016/j.bmc.2020.115700   
2020 Alam J. Vitamins: a nutritional intervention to modulate the Alzheimer's disease progression. Nutritional Neuroscience. 1-18. PMID 32998670 DOI: 10.1080/1028415X.2020.1826762   
2020 Javed I, Zhang Z, Adamcik J, Andrikopoulos N, Li Y, Otzen DE, Lin S, Mezzenga R, Davis TP, Ding F, Ke PC. Accelerated Amyloid Beta Pathogenesis by Bacterial Amyloid FapC. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). 7: 2001299. PMID 32999841 DOI: 10.1002/advs.202001299   
2020 Feng W, Zhang Y, Wang Z, Xu H, Wu T, Marshall C, Gao J, Xiao M. Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer's disease mouse model with suppression of glymphatic clearance. Alzheimer's Research & Therapy. 12: 125. PMID 33008458 DOI: 10.1186/s13195-020-00688-1   
2020 Gustavsson T, Syvänen S, O'Callaghan P, Sehlin D. SPECT imaging of distribution and retention of a brain-penetrating bispecific amyloid-β antibody in a mouse model of Alzheimer's disease. Translational Neurodegeneration. 9: 37. PMID 32951598 DOI: 10.1186/s40035-020-00214-1   
2020 Dong CM, Guo AS, To A, Chan KWY, Chow ASF, Bian L, Leong ATL, Wu EX. Early Detection of Amyloid β Pathology in Alzheimer's Disease by Molecular MRI. Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual International Conference. 2020: 1100-1103. PMID 33018178 DOI: 10.1109/EMBC44109.2020.9176013   
2020 Ma Y, McClatchy DB, Martínez-Bartolomé S, Bamberger C, Yates JR. Temporal Quantitative Profiling of Newly Synthesized Proteins during Aβ Accumulation. Journal of Proteome Research. PMID 33147027 DOI: 10.1021/acs.jproteome.0c00645   
2020 Dadar M, Camicioli R, Duchesne S, Collins DL, . The temporal relationships between white matter hyperintensities, neurodegeneration, amyloid beta, and cognition. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12091. PMID 33083512 DOI: 10.1002/dad2.12091   
2020 Borovkova M, Bykov A, Popov A, Pierangelo A, Novikova T, Pahnke J, Meglinski I. Evaluating β-amyloidosis progression in Alzheimer's disease with Mueller polarimetry. Biomedical Optics Express. 11: 4509-4519. PMID 32923060 DOI: 10.1364/BOE.396294   
2020 Kameyama M, Ishibashi K, Toyohara J, Wagatsuma K, Umeda-Kameyama Y, Shimoji K, Kanemaru K, Murayama S, Ogawa S, Tokumaru AM, Ishii K. Voxel-based morphometry focusing on medial temporal lobe structures has a limited capability to detect amyloid β, an Alzheimer's disease pathology. Aging. 12. PMID 33024054 DOI: 10.18632/aging.104012   
2020 Poon CH, Wang Y, Fung ML, Zhang C, Lim LW. Rodent Models of Amyloid-Beta Feature of Alzheimer's Disease: Development and Potential Treatment Implications. Aging and Disease. 11: 1235-1259. PMID 33014535 DOI: 10.14336/AD.2019.1026   
2020 Verberk IMW, Thijssen E, Koelewijn J, Mauroo K, Vanbrabant J, de Wilde A, Zwan MD, Verfaillie SCJ, Ossenkoppele R, Barkhof F, van Berckel BNM, Scheltens P, van der Flier WM, Stoops E, Vanderstichele HM, et al. Combination of plasma amyloid beta and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology. Alzheimer's Research & Therapy. 12: 118. PMID 32988409 DOI: 10.1186/s13195-020-00682-7   
2020 Feuillie C, Lambert E, Ewald M, Azouz M, Henry S, Marsaudon S, Cullin C, Lecomte S, Molinari M. High Speed AFM and NanoInfrared Spectroscopy Investigation of Aβ Peptide Variants and Their Interaction With POPC/SM/Chol/GM1 Model Membranes. Frontiers in Molecular Biosciences. 7: 571696. PMID 33033718 DOI: 10.3389/fmolb.2020.571696   
2020 Ma WH, Chen AF, Xie XY, Huang YS. Sigma ligands as potent inhibitors of Aβ and AβOs in neurons and promising therapeutic agents of Alzheimer's disease. Neuropharmacology. 108342. PMID 33045243 DOI: 10.1016/j.neuropharm.2020.108342   
2020 Cogswell PM, Wiste HJ, Senjem ML, Gunter JL, Weigand SD, Schwarz CG, Arani A, Therneau TM, Lowe VJ, Knopman DS, Botha H, Graff-Radford J, Jones DT, Kantarci K, Vemuri P, et al. Associations of Quantitative Susceptibility Mapping with Alzheimer's Disease Clinical and Imaging Markers. Neuroimage. 117433. PMID 33035667 DOI: 10.1016/j.neuroimage.2020.117433   
2020 d'Abramo C, D'Adamio L, Giliberto L. Significance of Blood and Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: Sensitivity, Specificity and Potential for Clinical Use. Journal of Personalized Medicine. 10. PMID 32911755 DOI: 10.3390/jpm10030116   
2020 Eke CS, Sakr F, Jammeh E, Zhao P, Ifeachor E. A Robust Blood-based Signature of Cerebrospinal Fluid Aβ Status. Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual International Conference. 2020: 5523-5526. PMID 33019230 DOI: 10.1109/EMBC44109.2020.9175158   
2020 Goyal MS, Gordon BA, Couture LE, Flores S, Xiong C, Morris JC, Raichle ME, L-S Benzinger T, Vlassenko AG. Spatiotemporal relationship between subthreshold amyloid accumulation and aerobic glycolysis in the human brain. Neurobiology of Aging. 96: 165-175. PMID 33011615 DOI: 10.1016/j.neurobiolaging.2020.08.019   
2020 Keshavan A, Wellington H, Chen Z, Khatun A, Chapman M, Hart M, Cash DM, Coath W, Parker TD, Buchanan SM, Keuss SE, Harris MJ, Murray-Smith H, Heslegrave A, Fox NC, et al. Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassays. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12097. PMID 32999915 DOI: 10.1002/dad2.12097   
2020 Garcia-Leon JA, Caceres-Palomo L, Sanchez-Mejias E, Mejias-Ortega M, Nuñez-Diaz C, Fernandez-Valenzuela JJ, Sanchez-Varo R, Davila JC, Vitorica J, Gutierrez A. Human Pluripotent Stem Cell-Derived Neural Cells as a Relevant Platform for Drug Screening in Alzheimer's Disease. International Journal of Molecular Sciences. 21. PMID 32962164 DOI: 10.3390/ijms21186867   
2020 Barman NC, Khan NM, Islam M, Nain Z, Roy RK, Haque A, Barman SK. CRISPR-Cas9: A Promising Genome Editing Therapeutic Tool for Alzheimer's Disease-A Narrative Review. Neurology and Therapy. PMID 33089409 DOI: 10.1007/s40120-020-00218-z   
2020 Qu X, Guan P, Han L, Wang Z, Huang X. Levistolide A Attenuates Alzheimer's Pathology Through Activation of the PPARγ Pathway. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 33034847 DOI: 10.1007/s13311-020-00943-1   
2020 Wu J, Cao C, Loch RA, Tiiman A, Luo J. Single-molecule studies of amyloid proteins: from biophysical properties to diagnostic perspectives. Quarterly Reviews of Biophysics. 53: e12. PMID 33148356 DOI: 10.1017/S0033583520000086   
2020 Osama A, Zhang J, Yao J, Yao X, Fang J. Nrf2: a dark horse in Alzheimer's disease treatment. Ageing Research Reviews. 101206. PMID 33144124 DOI: 10.1016/j.arr.2020.101206   
2020 Zhu F, Li C, Chu F, Tian X, Zhu J. Target Dysbiosis of Gut Microbes as a Future Therapeutic Manipulation in Alzheimer's Disease. Frontiers in Aging Neuroscience. 12: 544235. PMID 33132894 DOI: 10.3389/fnagi.2020.544235   
2020 Das S, Sengupta S, Chakraborty S. Scope of β-Secretase (BACE1)-Targeted Therapy in Alzheimer's Disease: Emphasizing the Flavonoid Based Natural Scaffold for BACE1 Inhibition. Acs Chemical Neuroscience. PMID 33073981 DOI: 10.1021/acschemneuro.0c00579   
2020 Do TM, Capdevila C, Pradier L, Blanchard V, Lopez-Grancha M, Schussler N, Steinmetz A, Beninga J, Boulay D, Dugay P, Verdier P, Aubin N, Dargazanli G, Chaves C, Genet E, et al. Tetravalent Bispecific Tandem Antibodies Improve Brain Exposure and Efficacy in an Amyloid Transgenic Mouse Model. Molecular Therapy. Methods & Clinical Development. 19: 58-77. PMID 33005703 DOI: 10.1016/j.omtm.2020.08.014   
2020 Scholes HM, Cryar A, Kerr F, Sutherland D, Gethings LA, Vissers JPC, Lees JG, Orengo CA, Partridge L, Thalassinos K. Dynamic changes in the brain protein interaction network correlates with progression of Aβ42 pathology in Drosophila. Scientific Reports. 10: 18517. PMID 33116184 DOI: 10.1038/s41598-020-74748-9   
2020 Mahan B, Antonelli MA, Burckel P, Turner S, Chung R, Habekost M, Jørgensen AL, Moynier F. Longitudinal biometal accumulation and Ca isotope composition of the Göttingen minipig brain. Metallomics : Integrated Biometal Science. 12: 1585-1598. PMID 33084720 DOI: 10.1039/d0mt00134a   
2020 Petekkaya E, Burakgazi G, Kuş B, Melek İM, Arpacı A. Comparative study of the volume of the temporal lobe sections and neuropeptide effect in Alzheimer's patients and healthy persons. The International Journal of Neuroscience. 1-10. PMID 33064056 DOI: 10.1080/00207454.2020.1831490   
2020 Lin G, Ji K, Li S, Ma W, Pan X. The Genetics Analysis of Molecular Pathogenesis for Alzheimer's Disease. European Neurology. 1-10. PMID 33027797 DOI: 10.1159/000509799   
2020 Cao J, Wang M, Gong C, Amakye WK, Sun X, Ren J. Identification of Microbiota within Aβ Plaque in APP/PS1 Transgenic Mouse. Journal of Molecular Neuroscience : Mn. PMID 33098544 DOI: 10.1007/s12031-020-01715-4   
2020 Ju Y, Chakravarty H, Tam KY. An Isoquinolinium Dual Inhibitor of Cholinesterases and Amyloid β Aggregation Mitigates Neuropathological Changes in a Triple-Transgenic Mouse Model of Alzheimer's Disease. Acs Chemical Neuroscience. PMID 33001625 DOI: 10.1021/acschemneuro.0c00464   
2020 Van Thanh Nguyen N, Taverna M, Smadja C, Mai TD. Recent Electrokinetic and Microfluidic Strategies for Detection of Amyloid Beta Peptide Biomarkers: Towards Molecular Diagnosis of Alzheimer's Disease. Chemical Record (New York, N.Y.). PMID 33112020 DOI: 10.1002/tcr.202000103   
2020 Sun BL, Chen Y, Fan DY, Zhu C, Zeng F, Wang YJ. Critical thinking on amyloid-beta-targeted therapy: challenges and perspectives. Science China. Life Sciences. PMID 33106917 DOI: 10.1007/s11427-020-1810-y   
2020 Chen XQ, Salehi A, Pearn ML, Overk C, Nguyen PD, Kleschevnikov AM, Maccecchini M, Mobley WC. Targeting increased levels of APP in Down syndrome: Posiphen-mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32975365 DOI: 10.1002/alz.12185   
2020 Kolanko MA, Win Z, Loreto F, Patel N, Carswell C, Gontsarova A, Perry RJ, Malhotra PA. Amyloid PET imaging in clinical practice. Practical Neurology. PMID 32973035 DOI: 10.1136/practneurol-2019-002468   
2020 Rafii MS, Ances BM, Schupf N, Krinsky-McHale SJ, Mapstone M, Silverman W, Lott I, Klunk W, Head E, Christian B, Lai F, Rosas HD, Zaman S, Petersen ME, Strydom A, et al. The AT(N) framework for Alzheimer's disease in adults with Down syndrome. Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12062. PMID 33134477 DOI: 10.1002/dad2.12062   
2020 Duggan MR, Torkzaban B, Ahooyi TM, Khalili K. Potential Role for Herpesviruses in Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 33074235 DOI: 10.3233/JAD-200814   
2020 Tan MS, Yang YX, Wang HF, Xu W, Tan CC, Zuo CT, Dong Q, Tan L, Yu JT, . PET Amyloid and Tau Status Are Differently Affected by Patient Features. Journal of Alzheimer's Disease : Jad. PMID 33104024 DOI: 10.3233/JAD-200124   
2020 Perea JR, Bolós M, Avila J. Microglia in Alzheimer's Disease in the Context of Tau Pathology. Biomolecules. 10. PMID 33066368 DOI: 10.3390/biom10101439   
2020 Pietroboni AM, Colombi A, Carandini T, Scarpini E, Galimberti D, Bozzali M. The Role of Amyloid-β in White Matter Damage: Possible Common Pathogenetic Mechanisms in Neurodegenerative and Demyelinating Diseases. Journal of Alzheimer's Disease : Jad. PMID 32925075 DOI: 10.3233/JAD-200868   
2020 Malarte ML, Nordberg A, Lemoine L. Characterization of MK6240, a tau PET tracer, in autopsy brain tissue from Alzheimer's disease cases. European Journal of Nuclear Medicine and Molecular Imaging. PMID 32970217 DOI: 10.1007/s00259-020-05035-y   
2020 Tudorascu DL, Laymon CM, Zammit M, Minhas DS, Anderson SJ, Ellison PA, Zaman S, Ances BM, Sabbagh M, Johnson SC, Mathis CA, Klunk WE, Handen BL, Christian BT, Cohen AD. Relationship of amyloid beta and neurofibrillary tau deposition in Neurodegeneration in Aging Down Syndrome (NiAD) study at baseline. Alzheimer's & Dementia (New York, N. Y.). 6: e12096. PMID 33163613 DOI: 10.1002/trc2.12096